Newsroom

Press Release - All

• 20 Jul 2021
  Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
• 20 Jul 2021
  Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
• 28 Jun 2021
  Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
• 22 Jun 2021
  Agilent Completes the InfinityLab Bio LC Portfolio
• 14 Jun 2021
  Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
• 04 Jun 2021
  Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
• 02 Jun 2021
  Agilent Announces New SureSelect Human All Exon V8
• 01 Jun 2021
  Agilent Presents Thought Leader Award to Professor Chris Elliott
• 27 May 2021
  Agilent Announces Winners of HPLC for Potency Testing Competition
• 25 May 2021
  Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results